What is the recommended dose of albuterol (salbutamol) for pediatric patients experiencing an asthma exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Albuterol Dosing for Asthma Exacerbation

For pediatric asthma exacerbations, the recommended albuterol dosing via MDI is 4-12 puffs with a valved holding chamber every 20-30 minutes for the first hour, then adjusted based on response. 1

Dosing by Administration Method

Metered-Dose Inhaler (MDI)

  • Children <15 kg: 4-8 puffs via MDI with valved holding chamber every 20 minutes for 3 doses, then as needed 2, 1
  • Children ≥15 kg: 4-12 puffs via MDI with valved holding chamber every 20-30 minutes for 3 doses, then as needed 1
  • Always use a spacer with valve and face mask for children under 10 kg 1

Nebulizer

  • Children <15 kg: 0.15 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg every 1-4 hours as needed 2
  • Children ≥15 kg: 2.5 mg every 20 minutes for 3 doses, then every 4-6 hours as needed 2, 1, 3
  • For children weighing <15 kg who require <2.5 mg/dose, use 0.5% albuterol solution instead of 0.083% 3

Treatment Approach Based on Exacerbation Severity

Mild Exacerbations

  • 4-12 puffs via MDI with valved holding chamber every 20-30 minutes for 3 doses 1
  • Reassess after initial treatment

Moderate to Severe Exacerbations

  • 3 treatments of albuterol administered every 20-30 minutes 2, 1
  • Consider adding ipratropium bromide for patients with incomplete or poor response 1, 4
    • Ipratropium has been shown to significantly reduce hospitalization rates in children with severe asthma exacerbations (37.5% vs 52.6%) 4
  • For severe cases, consider continuous nebulization at 0.5 mg/kg/hour (up to 20 mg/hour) 1, 5

Monitoring and Safety Considerations

  • Monitor respiratory rate, work of breathing, and oxygen saturation in all children 1
  • Continuous monitoring is essential for patients receiving high doses or continuous nebulization 1
  • Watch for potential side effects:
    • Cardiac effects (tachycardia)
    • Electrolyte disturbances (hypokalemia)
    • Tremor, hyperactivity, and vomiting 6

Important Clinical Pearls

  • Approximately 60-70% of patients will respond sufficiently to initial 3 doses to be discharged 1
  • High-dose albuterol (0.15 mg/kg) has been shown to be more effective than low-dose (0.05 mg/kg) in improving lung function and reducing hospitalization rates in severe asthma, without significant differences in side effects 6
  • Continuous nebulization (0.3 mg/kg/hr) has similar efficacy and safety to intermittent nebulization (0.15 mg/kg every 30 minutes) but may be more efficient in terms of healthcare provider time 7
  • Research has not identified an optimal weight-based dose of continuous albuterol, with doses ranging from 0.07-3.2 mg/kg/hr showing similar outcomes 5

Administration Tips

  • Dilute albuterol in a minimum of 2-3 mL of saline solution for adequate nebulization 1
  • Administer the entire contents of one sterile unit-dose vial (3 mL of 0.083% solution) by nebulization over approximately 5-15 minutes 3
  • If a previously effective dosage regimen fails to provide relief, seek medical advice immediately as this may indicate worsening asthma requiring reassessment 3

Remember that albuterol dosing should be adjusted based on clinical response, with close monitoring for both efficacy and potential side effects.

References

Guideline

Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Association of various weight-based doses of continuous albuterol on hospital length of stay.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2021

Research

Continuous vs intermittent nebulized albuterol for emergency management of asthma.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.